Marinos Dalakas Selected Research

Marinos Dalakas Research Topics

3	Multiple Sclerosis 04/2022 - 01/2020
2	Disease Progression 04/2022 - 04/2012
2	Myositis (Idiopathic Inflammatory Myopathies) 04/2014 - 07/2008
1	Autoimmune Diseases (Autoimmune Disease) 04/2012
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2011
1	Alzheimer Disease (Alzheimer's Disease) 07/2008
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 07/2008
1	Deglutition Disorders (Dysphagia) 07/2008
1	Inclusion Body Myositis 07/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2008
1	Pain (Aches) 07/2008
1	Fibrosis (Cirrhosis) 07/2008
1	Dermatomyositis (Dermatopolymyositis) 07/2008
1	Sleep Wake Disorders 07/2008
1	Nervous System Diseases (Neurological Disorders) 07/2008
1	Postpoliomyelitis Syndrome (Post-Polio Syndrome) 07/2008
1	Stiff-Person Syndrome (Stiff Man Syndrome) 07/2008
1	Demyelinating Diseases (Demyelinating Disease) 02/2007
1	Polyneuropathies (Polyneuropathy) 02/2007
1	Muscular Diseases (Myopathy) 01/2006
1	Rhabdomyosarcoma 01/2006

2	HLA-DRB1 Chains (HLA DRB1)IBA 04/2022 - 01/2020
2	AntibodiesIBA 07/2008 - 02/2007
1	HLA-DRB1*04 antigenIBA 04/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2022
1	Natalizumab (Tysabri)FDA Link 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 04/2014
1	Myelin-Associated GlycoproteinIBA 04/2012
1	Rituximab (Mabthera)FDA Link 04/2012
1	Monoclonal AntibodiesIBA 04/2012
1	AntigensIBA 04/2012
1	AutoantibodiesIBA 04/2012
1	Immunoglobulin G (IgG)IBA 04/2012
1	Immunoglobulin M (IgM)IBA 04/2012
1	Biomarkers (Surrogate Marker)IBA 06/2011
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2008
1	sulfate-3-glucuronyl paraglobosideIBA 02/2007
1	Glycoproteins (Glycoprotein)IBA 02/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2006
1	Messenger RNA (mRNA)IBA 01/2006
1	Interleukin-8 (Interleukin 8)IBA 01/2006

5	Therapeutics 04/2022 - 07/2008